A novel strategy to suppress prostate cancer growth
The researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.
Read moreThe researchers took a close look into what drives the growth of advanced tumors that have become resistant to standard castration therapy.
Read moreThe bone microenvironment prompts changes in breast cancer cells that help them escape treatment and become more invasive.
Read moreInhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.
Read moreDetailed 3-D studies reveal how the androgen receptor is put together as a functional complex that drives prostate cancer.
Read moreA fusion gene is a new gene made by joining parts of two different genes. The current thought is that fusion genes can happen in
Read moreThe five winners of this year’s Michael E. DeBakey M.D. Award for Research Excellence exemplify the breadth and depth of scientific research at Baylor College
Read moreGenetic factors can explain, at last in part, the higher incidence of prostate cancer among African American men compared with men of other ethnic groups.
Read moreDuring the month of September, Baylor College of Medicine will be partnering with the Blue Cure Foundation for its annual prostate cancer awareness campaign, Light
Read moreAdvanced prostate cancer is usually treated by removing androgen, the male hormone that helps it grow. Although initially effective, this treatment often leads to the
Read moreNearly 200 thousand men are diagnosed with prostate cancer every year. Most of the deaths associated with prostate cancer occur in advanced stages of the
Read more